Ozanimod

Common brands: Zeposia 7-Day Starter Pack, Zeposia Starter Kit, Zeposia, Vitamin D, Neurontin

Top reporter: Celgene Corporation

Provitamin D2 Compound [EPC]Corticosteroid [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Benzodiazepine [EPC]gamma-Aminobutyric Acid-ergic Agonist [EPC]
8,049
Total Reports
5,667
Serious Reports
86
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.07%)

Patient Demographics

Male
2,206
Female
5,455

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Ozanimod.

# Reaction Reports % of Total
1 FATIGUE 731
10.6%
2 MULTIPLE SCLEROSIS RELAPSE 577
8.4%
3 DRUG INEFFECTIVE 542
7.9%
4 HEADACHE 504
7.3%
5 PRODUCT DOSE OMISSION ISSUE 356
5.2%
6 DIZZINESS 338
4.9%
7 NAUSEA 281
4.1%
8 DIARRHOEA 261
3.8%
9 COLITIS ULCERATIVE 252
3.7%
10 PAIN 250
3.6%
11 BACK PAIN 212
3.1%
12 ADVERSE EVENT 186
2.7%
13 FALL 178
2.6%
14 MULTIPLE SCLEROSIS 174
2.5%
15 DYSPNOEA 153
2.2%
16 HYPOAESTHESIA 148
2.1%
17 ARTHRALGIA 143
2.1%
18 HYPERTENSION 137
2.0%
19 ASTHENIA 135
2.0%
20 COVID-19 132
1.9%
21 DEPRESSION 132
1.9%
22 GAIT DISTURBANCE 122
1.8%
23 PAIN IN EXTREMITY 122
1.8%
24 OFF LABEL USE 120
1.7%
25 RASH 119
1.7%
26 URINARY TRACT INFECTION 119
1.7%
27 VOMITING 119
1.7%
28 BLOOD PRESSURE INCREASED 116
1.7%
29 LYMPHOCYTE COUNT DECREASED 115
1.7%
30 PARAESTHESIA 115
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.